Last Updated : February 16, 2023
Drug manufacturers or designated consultants that plan to submit a drug for review under the CADTH Reimbursement Review program must register for the Pharmaceutical Submissions SharePoint site. This is effective for new submissions that have not submitted an advance notification as of February 16, 2023.
CADTH will be transitioning active reviews that are currently using Collaborative Workspaces to SharePoint on a rolling basis. Sponsors with already submitted or active reviews should wait until a CADTH administrator reaches out to them to request that they register for the Pharmaceutical Submissions SharePoint site.
Please note, if you require assistance using the legacy system, Collaborative Workspaces, please email [email protected].
How to Register for Pharmaceutical Submissions SharePoint Site
Complete the Pharmaceutical Submissions SharePoint Site Access Request Form and send it to [email protected] a minimum of 10 business days before the intended date of submitting the Pre-submission Meeting Request Form (or Advance Notification Form if not requesting a pre-submission meeting).
Download the Microsoft Authenticator App on your smartphone.
CADTH will send you a link to log in along with further information for completing your registration.
Finalize your access by proceeding with the steps outlined in the Pharmaceutical Submissions SharePoint Site Set-Up Guide.
If you have an existing account with the CADTH Pharmaceutical Submissions SharePoint site for one project but require access to submit another drug for review, you must get additional access by using the same steps.
If you have any questions about the registration process, please email us at [email protected].
Use the following forms to register as a manufacturer or designated consultant for the pharmaceutical reviews programs: